Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Hip Implants Market

ID: MRFR/HC/6976-HCR
111 Pages
Nidhi Mandole
Last Updated: May 15, 2026

Hip Implants Market Research Report Information By Product (Total Hip implants, Fixed-Bearing Hip Implants, Mobile-Bearing Total Hip Implants, Partial Hip implants, Hip Resurfacing Implants and Revision Hip implants), By End-User (Hospitals, Orthopedic Clinics and Ambulatory Surgical Centers), By Material (Metal-on-Polyethylene, Ceramic-on-Metal, Metal-on-Metal, Ceramic-on-Polyethylene and Ceramic-on-Ceramic), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Hip Implants Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Application (USD Billion)
  49.     4.1.1 Total Hip Replacement
  50.     4.1.2 Partial Hip Replacement
  51.     4.1.3 Hip Resurfacing
  52.   4.2 Healthcare, BY Material (USD Billion)
  53.     4.2.1 Metal
  54.     4.2.2 Ceramic
  55.     4.2.3 Polyethylene
  56.     4.2.4 Composite
  57.   4.3 Healthcare, BY End Use (USD Billion)
  58.     4.3.1 Hospitals
  59.     4.3.2 Ambulatory Surgical Centers
  60.     4.3.3 Orthopedic Clinics
  61.   4.4 Healthcare, BY Fixation Type (USD Billion)
  62.     4.4.1 Cemented
  63.     4.4.2 Cementless
  64.     4.4.3 Hybrid
  65.   4.5 Healthcare, BY Patient Demographics (USD Billion)
  66.     4.5.1 Age Group
  67.     4.5.2 Gender
  68.     4.5.3 Activity Level
  69.   4.6 Healthcare, BY Region (USD Billion)
  70.     4.6.1 North America
  71.       4.6.1.1 US
  72.       4.6.1.2 Canada
  73.     4.6.2 Europe
  74.       4.6.2.1 Germany
  75.       4.6.2.2 UK
  76.       4.6.2.3 France
  77.       4.6.2.4 Russia
  78.       4.6.2.5 Italy
  79.       4.6.2.6 Spain
  80.       4.6.2.7 Rest of Europe
  81.     4.6.3 APAC
  82.       4.6.3.1 China
  83.       4.6.3.2 India
  84.       4.6.3.3 Japan
  85.       4.6.3.4 South Korea
  86.       4.6.3.5 Malaysia
  87.       4.6.3.6 Thailand
  88.       4.6.3.7 Indonesia
  89.       4.6.3.8 Rest of APAC
  90.     4.6.4 South America
  91.       4.6.4.1 Brazil
  92.       4.6.4.2 Mexico
  93.       4.6.4.3 Argentina
  94.       4.6.4.4 Rest of South America
  95.     4.6.5 MEA
  96.       4.6.5.1 GCC Countries
  97.       4.6.5.2 South Africa
  98.       4.6.5.3 Rest of MEA
  99. 5 SECTION V: COMPETITIVE ANALYSIS
  100.   5.1 Competitive Landscape
  101.     5.1.1 Overview
  102.     5.1.2 Competitive Analysis
  103.     5.1.3 Market share Analysis
  104.     5.1.4 Major Growth Strategy in the Healthcare
  105.     5.1.5 Competitive Benchmarking
  106.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  107.     5.1.7 Key developments and growth strategies
  108.       5.1.7.1 New Product Launch/Service Deployment
  109.       5.1.7.2 Merger & Acquisitions
  110.       5.1.7.3 Joint Ventures
  111.     5.1.8 Major Players Financial Matrix
  112.       5.1.8.1 Sales and Operating Income
  113.       5.1.8.2 Major Players R&D Expenditure. 2023
  114.   5.2 Company Profiles
  115.     5.2.1 DePuy Synthes (US)
  116.       5.2.1.1 Financial Overview
  117.       5.2.1.2 Products Offered
  118.       5.2.1.3 Key Developments
  119.       5.2.1.4 SWOT Analysis
  120.       5.2.1.5 Key Strategies
  121.     5.2.2 Stryker (US)
  122.       5.2.2.1 Financial Overview
  123.       5.2.2.2 Products Offered
  124.       5.2.2.3 Key Developments
  125.       5.2.2.4 SWOT Analysis
  126.       5.2.2.5 Key Strategies
  127.     5.2.3 Zimmer Biomet (US)
  128.       5.2.3.1 Financial Overview
  129.       5.2.3.2 Products Offered
  130.       5.2.3.3 Key Developments
  131.       5.2.3.4 SWOT Analysis
  132.       5.2.3.5 Key Strategies
  133.     5.2.4 Smith & Nephew (GB)
  134.       5.2.4.1 Financial Overview
  135.       5.2.4.2 Products Offered
  136.       5.2.4.3 Key Developments
  137.       5.2.4.4 SWOT Analysis
  138.       5.2.4.5 Key Strategies
  139.     5.2.5 Medtronic (US)
  140.       5.2.5.1 Financial Overview
  141.       5.2.5.2 Products Offered
  142.       5.2.5.3 Key Developments
  143.       5.2.5.4 SWOT Analysis
  144.       5.2.5.5 Key Strategies
  145.     5.2.6 Exactech (US)
  146.       5.2.6.1 Financial Overview
  147.       5.2.6.2 Products Offered
  148.       5.2.6.3 Key Developments
  149.       5.2.6.4 SWOT Analysis
  150.       5.2.6.5 Key Strategies
  151.     5.2.7 B. Braun (DE)
  152.       5.2.7.1 Financial Overview
  153.       5.2.7.2 Products Offered
  154.       5.2.7.3 Key Developments
  155.       5.2.7.4 SWOT Analysis
  156.       5.2.7.5 Key Strategies
  157.     5.2.8 Aesculap (DE)
  158.       5.2.8.1 Financial Overview
  159.       5.2.8.2 Products Offered
  160.       5.2.8.3 Key Developments
  161.       5.2.8.4 SWOT Analysis
  162.       5.2.8.5 Key Strategies
  163.     5.2.9 Wright Medical (US)
  164.       5.2.9.1 Financial Overview
  165.       5.2.9.2 Products Offered
  166.       5.2.9.3 Key Developments
  167.       5.2.9.4 SWOT Analysis
  168.       5.2.9.5 Key Strategies
  169.   5.3 Appendix
  170.     5.3.1 References
  171.     5.3.2 Related Reports
  172. 6 LIST OF FIGURES
  173.   6.1 MARKET SYNOPSIS
  174.   6.2 NORTH AMERICA MARKET ANALYSIS
  175.   6.3 US MARKET ANALYSIS BY APPLICATION
  176.   6.4 US MARKET ANALYSIS BY MATERIAL
  177.   6.5 US MARKET ANALYSIS BY END USE
  178.   6.6 US MARKET ANALYSIS BY FIXATION TYPE
  179.   6.7 US MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  180.   6.8 CANADA MARKET ANALYSIS BY APPLICATION
  181.   6.9 CANADA MARKET ANALYSIS BY MATERIAL
  182.   6.10 CANADA MARKET ANALYSIS BY END USE
  183.   6.11 CANADA MARKET ANALYSIS BY FIXATION TYPE
  184.   6.12 CANADA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  185.   6.13 EUROPE MARKET ANALYSIS
  186.   6.14 GERMANY MARKET ANALYSIS BY APPLICATION
  187.   6.15 GERMANY MARKET ANALYSIS BY MATERIAL
  188.   6.16 GERMANY MARKET ANALYSIS BY END USE
  189.   6.17 GERMANY MARKET ANALYSIS BY FIXATION TYPE
  190.   6.18 GERMANY MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  191.   6.19 UK MARKET ANALYSIS BY APPLICATION
  192.   6.20 UK MARKET ANALYSIS BY MATERIAL
  193.   6.21 UK MARKET ANALYSIS BY END USE
  194.   6.22 UK MARKET ANALYSIS BY FIXATION TYPE
  195.   6.23 UK MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  196.   6.24 FRANCE MARKET ANALYSIS BY APPLICATION
  197.   6.25 FRANCE MARKET ANALYSIS BY MATERIAL
  198.   6.26 FRANCE MARKET ANALYSIS BY END USE
  199.   6.27 FRANCE MARKET ANALYSIS BY FIXATION TYPE
  200.   6.28 FRANCE MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  201.   6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
  202.   6.30 RUSSIA MARKET ANALYSIS BY MATERIAL
  203.   6.31 RUSSIA MARKET ANALYSIS BY END USE
  204.   6.32 RUSSIA MARKET ANALYSIS BY FIXATION TYPE
  205.   6.33 RUSSIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  206.   6.34 ITALY MARKET ANALYSIS BY APPLICATION
  207.   6.35 ITALY MARKET ANALYSIS BY MATERIAL
  208.   6.36 ITALY MARKET ANALYSIS BY END USE
  209.   6.37 ITALY MARKET ANALYSIS BY FIXATION TYPE
  210.   6.38 ITALY MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  211.   6.39 SPAIN MARKET ANALYSIS BY APPLICATION
  212.   6.40 SPAIN MARKET ANALYSIS BY MATERIAL
  213.   6.41 SPAIN MARKET ANALYSIS BY END USE
  214.   6.42 SPAIN MARKET ANALYSIS BY FIXATION TYPE
  215.   6.43 SPAIN MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  216.   6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  217.   6.45 REST OF EUROPE MARKET ANALYSIS BY MATERIAL
  218.   6.46 REST OF EUROPE MARKET ANALYSIS BY END USE
  219.   6.47 REST OF EUROPE MARKET ANALYSIS BY FIXATION TYPE
  220.   6.48 REST OF EUROPE MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  221.   6.49 APAC MARKET ANALYSIS
  222.   6.50 CHINA MARKET ANALYSIS BY APPLICATION
  223.   6.51 CHINA MARKET ANALYSIS BY MATERIAL
  224.   6.52 CHINA MARKET ANALYSIS BY END USE
  225.   6.53 CHINA MARKET ANALYSIS BY FIXATION TYPE
  226.   6.54 CHINA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  227.   6.55 INDIA MARKET ANALYSIS BY APPLICATION
  228.   6.56 INDIA MARKET ANALYSIS BY MATERIAL
  229.   6.57 INDIA MARKET ANALYSIS BY END USE
  230.   6.58 INDIA MARKET ANALYSIS BY FIXATION TYPE
  231.   6.59 INDIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  232.   6.60 JAPAN MARKET ANALYSIS BY APPLICATION
  233.   6.61 JAPAN MARKET ANALYSIS BY MATERIAL
  234.   6.62 JAPAN MARKET ANALYSIS BY END USE
  235.   6.63 JAPAN MARKET ANALYSIS BY FIXATION TYPE
  236.   6.64 JAPAN MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  237.   6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  238.   6.66 SOUTH KOREA MARKET ANALYSIS BY MATERIAL
  239.   6.67 SOUTH KOREA MARKET ANALYSIS BY END USE
  240.   6.68 SOUTH KOREA MARKET ANALYSIS BY FIXATION TYPE
  241.   6.69 SOUTH KOREA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  242.   6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
  243.   6.71 MALAYSIA MARKET ANALYSIS BY MATERIAL
  244.   6.72 MALAYSIA MARKET ANALYSIS BY END USE
  245.   6.73 MALAYSIA MARKET ANALYSIS BY FIXATION TYPE
  246.   6.74 MALAYSIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  247.   6.75 THAILAND MARKET ANALYSIS BY APPLICATION
  248.   6.76 THAILAND MARKET ANALYSIS BY MATERIAL
  249.   6.77 THAILAND MARKET ANALYSIS BY END USE
  250.   6.78 THAILAND MARKET ANALYSIS BY FIXATION TYPE
  251.   6.79 THAILAND MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  252.   6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
  253.   6.81 INDONESIA MARKET ANALYSIS BY MATERIAL
  254.   6.82 INDONESIA MARKET ANALYSIS BY END USE
  255.   6.83 INDONESIA MARKET ANALYSIS BY FIXATION TYPE
  256.   6.84 INDONESIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  257.   6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
  258.   6.86 REST OF APAC MARKET ANALYSIS BY MATERIAL
  259.   6.87 REST OF APAC MARKET ANALYSIS BY END USE
  260.   6.88 REST OF APAC MARKET ANALYSIS BY FIXATION TYPE
  261.   6.89 REST OF APAC MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  262.   6.90 SOUTH AMERICA MARKET ANALYSIS
  263.   6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
  264.   6.92 BRAZIL MARKET ANALYSIS BY MATERIAL
  265.   6.93 BRAZIL MARKET ANALYSIS BY END USE
  266.   6.94 BRAZIL MARKET ANALYSIS BY FIXATION TYPE
  267.   6.95 BRAZIL MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  268.   6.96 MEXICO MARKET ANALYSIS BY APPLICATION
  269.   6.97 MEXICO MARKET ANALYSIS BY MATERIAL
  270.   6.98 MEXICO MARKET ANALYSIS BY END USE
  271.   6.99 MEXICO MARKET ANALYSIS BY FIXATION TYPE
  272.   6.100 MEXICO MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  273.   6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
  274.   6.102 ARGENTINA MARKET ANALYSIS BY MATERIAL
  275.   6.103 ARGENTINA MARKET ANALYSIS BY END USE
  276.   6.104 ARGENTINA MARKET ANALYSIS BY FIXATION TYPE
  277.   6.105 ARGENTINA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  278.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  279.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY MATERIAL
  280.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
  281.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY FIXATION TYPE
  282.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  283.   6.111 MEA MARKET ANALYSIS
  284.   6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  285.   6.113 GCC COUNTRIES MARKET ANALYSIS BY MATERIAL
  286.   6.114 GCC COUNTRIES MARKET ANALYSIS BY END USE
  287.   6.115 GCC COUNTRIES MARKET ANALYSIS BY FIXATION TYPE
  288.   6.116 GCC COUNTRIES MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  289.   6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  290.   6.118 SOUTH AFRICA MARKET ANALYSIS BY MATERIAL
  291.   6.119 SOUTH AFRICA MARKET ANALYSIS BY END USE
  292.   6.120 SOUTH AFRICA MARKET ANALYSIS BY FIXATION TYPE
  293.   6.121 SOUTH AFRICA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  294.   6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
  295.   6.123 REST OF MEA MARKET ANALYSIS BY MATERIAL
  296.   6.124 REST OF MEA MARKET ANALYSIS BY END USE
  297.   6.125 REST OF MEA MARKET ANALYSIS BY FIXATION TYPE
  298.   6.126 REST OF MEA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  299.   6.127 KEY BUYING CRITERIA OF HEALTHCARE
  300.   6.128 RESEARCH PROCESS OF MRFR
  301.   6.129 DRO ANALYSIS OF HEALTHCARE
  302.   6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  303.   6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  304.   6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
  305.   6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  306.   6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  307.   6.135 HEALTHCARE, BY MATERIAL, 2024 (% SHARE)
  308.   6.136 HEALTHCARE, BY MATERIAL, 2024 TO 2035 (USD Billion)
  309.   6.137 HEALTHCARE, BY END USE, 2024 (% SHARE)
  310.   6.138 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
  311.   6.139 HEALTHCARE, BY FIXATION TYPE, 2024 (% SHARE)
  312.   6.140 HEALTHCARE, BY FIXATION TYPE, 2024 TO 2035 (USD Billion)
  313.   6.141 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
  314.   6.142 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Billion)
  315.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  316. 7 LIST OF TABLES
  317.   7.1 LIST OF ASSUMPTIONS
  318.     7.1.1
  319.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  320.     7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
  321.     7.2.2 BY MATERIAL, 2025-2035 (USD Billion)
  322.     7.2.3 BY END USE, 2025-2035 (USD Billion)
  323.     7.2.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  324.     7.2.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  325.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  326.     7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
  327.     7.3.2 BY MATERIAL, 2025-2035 (USD Billion)
  328.     7.3.3 BY END USE, 2025-2035 (USD Billion)
  329.     7.3.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  330.     7.3.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  331.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  332.     7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
  333.     7.4.2 BY MATERIAL, 2025-2035 (USD Billion)
  334.     7.4.3 BY END USE, 2025-2035 (USD Billion)
  335.     7.4.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  336.     7.4.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  337.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  338.     7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
  339.     7.5.2 BY MATERIAL, 2025-2035 (USD Billion)
  340.     7.5.3 BY END USE, 2025-2035 (USD Billion)
  341.     7.5.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  342.     7.5.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  343.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  344.     7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
  345.     7.6.2 BY MATERIAL, 2025-2035 (USD Billion)
  346.     7.6.3 BY END USE, 2025-2035 (USD Billion)
  347.     7.6.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  348.     7.6.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  349.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  350.     7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
  351.     7.7.2 BY MATERIAL, 2025-2035 (USD Billion)
  352.     7.7.3 BY END USE, 2025-2035 (USD Billion)
  353.     7.7.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  354.     7.7.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  355.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  356.     7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
  357.     7.8.2 BY MATERIAL, 2025-2035 (USD Billion)
  358.     7.8.3 BY END USE, 2025-2035 (USD Billion)
  359.     7.8.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  360.     7.8.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  361.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  362.     7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
  363.     7.9.2 BY MATERIAL, 2025-2035 (USD Billion)
  364.     7.9.3 BY END USE, 2025-2035 (USD Billion)
  365.     7.9.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  366.     7.9.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  367.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  368.     7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
  369.     7.10.2 BY MATERIAL, 2025-2035 (USD Billion)
  370.     7.10.3 BY END USE, 2025-2035 (USD Billion)
  371.     7.10.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  372.     7.10.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  373.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  374.     7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
  375.     7.11.2 BY MATERIAL, 2025-2035 (USD Billion)
  376.     7.11.3 BY END USE, 2025-2035 (USD Billion)
  377.     7.11.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  378.     7.11.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  379.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  380.     7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
  381.     7.12.2 BY MATERIAL, 2025-2035 (USD Billion)
  382.     7.12.3 BY END USE, 2025-2035 (USD Billion)
  383.     7.12.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  384.     7.12.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  385.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  386.     7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
  387.     7.13.2 BY MATERIAL, 2025-2035 (USD Billion)
  388.     7.13.3 BY END USE, 2025-2035 (USD Billion)
  389.     7.13.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  390.     7.13.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  391.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  392.     7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
  393.     7.14.2 BY MATERIAL, 2025-2035 (USD Billion)
  394.     7.14.3 BY END USE, 2025-2035 (USD Billion)
  395.     7.14.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  396.     7.14.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  397.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  398.     7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
  399.     7.15.2 BY MATERIAL, 2025-2035 (USD Billion)
  400.     7.15.3 BY END USE, 2025-2035 (USD Billion)
  401.     7.15.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  402.     7.15.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  403.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  404.     7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
  405.     7.16.2 BY MATERIAL, 2025-2035 (USD Billion)
  406.     7.16.3 BY END USE, 2025-2035 (USD Billion)
  407.     7.16.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  408.     7.16.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  409.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  410.     7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
  411.     7.17.2 BY MATERIAL, 2025-2035 (USD Billion)
  412.     7.17.3 BY END USE, 2025-2035 (USD Billion)
  413.     7.17.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  414.     7.17.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  415.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  416.     7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
  417.     7.18.2 BY MATERIAL, 2025-2035 (USD Billion)
  418.     7.18.3 BY END USE, 2025-2035 (USD Billion)
  419.     7.18.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  420.     7.18.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  421.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  422.     7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
  423.     7.19.2 BY MATERIAL, 2025-2035 (USD Billion)
  424.     7.19.3 BY END USE, 2025-2035 (USD Billion)
  425.     7.19.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  426.     7.19.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  427.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  428.     7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
  429.     7.20.2 BY MATERIAL, 2025-2035 (USD Billion)
  430.     7.20.3 BY END USE, 2025-2035 (USD Billion)
  431.     7.20.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  432.     7.20.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  433.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  434.     7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
  435.     7.21.2 BY MATERIAL, 2025-2035 (USD Billion)
  436.     7.21.3 BY END USE, 2025-2035 (USD Billion)
  437.     7.21.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  438.     7.21.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  439.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  440.     7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
  441.     7.22.2 BY MATERIAL, 2025-2035 (USD Billion)
  442.     7.22.3 BY END USE, 2025-2035 (USD Billion)
  443.     7.22.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  444.     7.22.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  445.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  446.     7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
  447.     7.23.2 BY MATERIAL, 2025-2035 (USD Billion)
  448.     7.23.3 BY END USE, 2025-2035 (USD Billion)
  449.     7.23.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  450.     7.23.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  451.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  452.     7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
  453.     7.24.2 BY MATERIAL, 2025-2035 (USD Billion)
  454.     7.24.3 BY END USE, 2025-2035 (USD Billion)
  455.     7.24.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  456.     7.24.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  457.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  458.     7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
  459.     7.25.2 BY MATERIAL, 2025-2035 (USD Billion)
  460.     7.25.3 BY END USE, 2025-2035 (USD Billion)
  461.     7.25.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  462.     7.25.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  463.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  464.     7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
  465.     7.26.2 BY MATERIAL, 2025-2035 (USD Billion)
  466.     7.26.3 BY END USE, 2025-2035 (USD Billion)
  467.     7.26.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  468.     7.26.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  469.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  470.     7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
  471.     7.27.2 BY MATERIAL, 2025-2035 (USD Billion)
  472.     7.27.3 BY END USE, 2025-2035 (USD Billion)
  473.     7.27.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  474.     7.27.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  475.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  476.     7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
  477.     7.28.2 BY MATERIAL, 2025-2035 (USD Billion)
  478.     7.28.3 BY END USE, 2025-2035 (USD Billion)
  479.     7.28.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  480.     7.28.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  481.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  482.     7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
  483.     7.29.2 BY MATERIAL, 2025-2035 (USD Billion)
  484.     7.29.3 BY END USE, 2025-2035 (USD Billion)
  485.     7.29.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  486.     7.29.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  487.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  488.     7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
  489.     7.30.2 BY MATERIAL, 2025-2035 (USD Billion)
  490.     7.30.3 BY END USE, 2025-2035 (USD Billion)
  491.     7.30.4 BY FIXATION TYPE, 2025-2035 (USD Billion)
  492.     7.30.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Billion)
  493.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  494.     7.31.1
  495.   7.32 ACQUISITION/PARTNERSHIP
  496.     7.32.1

Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2025-2035)

  • Total Hip Replacement
  • Partial Hip Replacement
  • Hip Resurfacing

Healthcare By Material (USD Billion, 2025-2035)

  • Metal
  • Ceramic
  • Polyethylene
  • Composite

Healthcare By End Use (USD Billion, 2025-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Orthopedic Clinics

Healthcare By Fixation Type (USD Billion, 2025-2035)

  • Cemented
  • Cementless
  • Hybrid

Healthcare By Patient Demographics (USD Billion, 2025-2035)

  • Age Group
  • Gender
  • Activity Level

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions